Surgical Robot Challenge 2016 Now Open For Entries From International Teams

London, United Kingdom, 18th December 2015 – The world’s pioneering researchers in robotic surgery are invited to showcase their innovative work by taking part in the Surgical Robot Challenge 2016. The Surgical Robot Challenge is open for entry from today, and the competition finals will be held from 20 – 27 June 2016 at the Hamlyn Symposium on Medical Robotics in London, as part of the first ever UK Robotics Week. Full details of the competition and how to enter can be found at:

This international competition annually showcases cutting-edge advances in surgical robot technologies. Teams from around the world will be bringing their surgical robots to London in June to demonstrate their latest innovations. Each team will be given 3 hours to set up and demonstrate their technologies to an independent judging panel of leading surgeons and pioneers in the field, competing for a prize fund of 10,000 GBP.

Mobile fleet operator sets its sights on European expansion

Gloucester, UK, 3rd February 2015 – The operator of the world’s largest fleet of mobile operating theatres is targeting expansion in Europe in the wake of the ECB’s plan to inject €1.1 trillion into the Eurozone.

Vanguard Healthcare has appointed Mary Smallbone to the newly-created post of Managing Director Europe and is rolling out its UK-developed healthcare technology into mainland Europe.

Smallbone, a qualified theatre nurse, ran regional sales teams for Smith & Nephew before joining Vanguard in 2003 as Director of Sales and Marketing. She added Operations to her portfolio in 2007 and has already overseen contracts for the company in Italy, Belgium, the Netherlands and Sweden.

Vanguard’s main business is providing mobile operating theatres and mobile wards, usually with experienced theatre staff, to NHS and private hospitals in the UK. More than 200,000 patients have been treated on its fleet of 37 mobiles which include three mobile endoscopy units.

DNA Electronics appoints Nick McCooke as Chief Business Officer

London, UK, 10th June 2014 – DNA Electronics Ltd (DNAe), a provider of point-of-care genomic diagnostics solutions for medical and healthcare applications, today announces the appointment of Nick McCooke as Chief Business Officer as it continues to build its management team.

Mr McCooke brings 30 years of senior management experience in Healthcare businesses. As CEO of Solexa, from its spin-out from the University of Cambridge in 2000 to its NASDAQ listing in 2005, he led the development of the world’s leading Next Generation DNA Sequencing (NGS) technology, which is the basis of Illumina’s current product line.

Mr McCooke comments: “I’m thrilled to be joining DNAe at this exciting point in the company’s evolution. I was proud to be part of the NGS revolution ten years ago and I believe that bringing the technology to clinicians at the point of need is the next revolution.”

Charity ORBIS saves sight of child with 200,000th surgery procedure

November 1st, 2012 - A blind teenage girl from Zambia was the 200,000th children’s surgery case by sight saving charity ORBIS. 14 year old Memory Chonga received a cataract operation at the recently opened ORBIS Paediatric Eye Care Centre in Kitwe.
Before the operation Memory’s condition, which developed overtime, caused severe clouding of her eyes and almost total loss of her sight. It caused her depression and to withdraw from normal life. But now Memory’s outlook is totally changed. Her vision is now good and she spends as much time as possible reading whatever she can lay her hands on, a pleasure that has recently been denied to her because of her gradual sight lost. When asked what she thought of her ‘new eyes’ she exclaimed: “Praises, praises, thank you, praises, thank you.”
Memory’s sight saving operation is just one of a raft of impressive milestones reached by ORBIS and its partners in its 30th anniversary year:-

Subscribe to RSS - Medical